Mural Oncology
Stock Forecast, Prediction & Price Target
Mural Oncology Financial Estimates
Mural Oncology Revenue Estimates
Mural Oncology EBITDA Estimates
Mural Oncology Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $26.05M Low: $26.05M High: $26.05M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $12.4M Low: $12.4M High: $12.4M avg. 0% |
Net Income
% change YoY
| $-175.43M N/A | $-200.03M -14.02% | $-207.44M -3.70% | Avg: $-88.28M Low: $-88.28M High: $-88.28M avg. 57.44% | Avg: $-60.58M Low: $-60.58M High: $-60.58M avg. 31.37% | Avg: $-79.27M Low: $-79.27M High: $-79.27M avg. -30.85% | Avg: $-74.26M Low: $-74.26M High: $-74.26M avg. 6.31% |
EBITDA
% change YoY
| $-173.89M N/A | $-193.60M -11.33% | $-192.72M 0.45% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$10.51 N/A | -$11.99 -14.08% | -$12.43 -3.66% | Avg: -$5.29 Low: -$5.29 High: -$5.29 avg. 57.44% | Avg: -$3.63 Low: -$3.63 High: -$3.63 avg. 31.37% | Avg: -$4.75 Low: -$4.75 High: -$4.75 avg. -30.85% | Avg: -$4.45 Low: -$4.45 High: -$4.45 avg. 6.31% |
Operating Expenses
% change YoY
| $175.36M N/A | $195.14M 11.27% | $192.07M -1.57% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Mural Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.07% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -88.28M, average is -88.28M and high is -88.28M.
What is Mural Oncology stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Mural Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.07% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$5.29, average is -$5.29 and high is $-5.29.